קוסליוגו 10 מ"ג - Koselugo 10 mg

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

××× ×× ×× × ××¡×¤××

×§××¡××××× 25 ×"× - Koselugo 25 mg

×§×××¦× ×¤×¨××§××××××ª (ATC4)

L01EE
Mitogen-activated protein kinase (MEK) inhibitors

××¨××× ×¤×¢×× (ATC5)

Selumetinib AS HYD-SULFATE 10 MG âL01EE04

×¦××¨×ª ××ª×

×¤××× - PER OS

×¦××¨×ª ××× ××

×§×¤×¡××× ×§×©×××, HARD CAPSULE
××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××

××ª××××

Koselugo is indicated for the treatment of pediatric patients 2 years of age and older withneurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN).

× ×ª×× × ××¡×

×ª××¨×× ××××× ××¡×

03/02/2022

××××××ª ××¡×

×ª×¨××¤× ××××××ª ××¨××©×× ×¢'× ×¨××¤× ××××× ×× ××××× ×××¨×ª

××ª×××× ××¡×

××ª××××	×ª××¨×× ×××××	×ª××× ×§××× ×	Class Effect	××¦× ××××	××¡××¡ ××××××ª

××¡××¨×ª ××××× ××¡×

×. ××ª×¨××¤× ×ª×× ×ª× ××××¤×× ×× ×××¨××¤×××¨×××××××¡ ××¡×× 1 ××××× ×× ×©× ×ª××× ×××¢×× ×¢× × ×××¨××¤×××¨××××ª ×¤××§×¡××¤××¨××××ª, ×¡×××¤×××××××ª ×××ª× × ×ª××××ª, ×××¤×¨××¢××ª ××ª×¤×§××× ×©× ×××××.

×¢××× ××¨××¤× ×××××¨××ª ××¢×××

×¢××× ××¨××¤× 30.06.2021

××××¨× ××¢××× 30.06.2021

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 30.06.2021 ×¢××× ××¦×¨×× ×× ××××ª Patient information leafletâ 30.06.2021 ×¢××× ××¦×¨×× ×¢×¨×××ª ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 30.06.2021

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×§××¡××××× 10 ×"× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	ASTRA ZENECA UK LIMITED
×©× ××¢× ××¨××©××	ASTRAZENECA (ISRAEL) LTD
×¨××©×××	×ª××¨×× ×××©×: 5/2020. ×¨××©××× ××ª××¨××:
×ª××¨×× ×¢×××× ×××¨××

השינוי האחרון נעשה בֹ־2 באוגוסט 2023 ב־11:20

קוסליוגו 10 מ"ג - Koselugo 10 mg

ויקיתרופות